Autonomous Therapeutics, Inc.
Publicly observedSilver Spring, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Silver Spring | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Autonomous Therapeutics, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | JFHPX6TUYMU8 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant10 Sept 2025Publicly observed
NIH SBIR/STTR award: AT191: An inhaled & precision RNA therapeutic with pan-variant SARS-CoV-2 efficacy
USD 976,628.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant10 Sept 2025Publicly observed
NIH SBIR/STTR award: AT191: An inhaled & precision RNA therapeutic with pan-variant SARS-CoV-2 efficacy
USD 1,004,473.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.